These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of transtubular transport inhibitors in the renal excretion of uric acid in the rat]. Boudry JF. Pflugers Arch; 1971; 328(4):279-91. PubMed ID: 5107270 [No Abstract] [Full Text] [Related]
3. [Intrarenal blood distribution in chronic kidney diseases in childhood]. Grossmann P, Zoellner K. Z Urol Nephrol; 1971 Jan; 64(1):15-22. PubMed ID: 5124714 [No Abstract] [Full Text] [Related]
4. Pyrazinoate excretion in the chimpanzee. Relation to urate disposition and the actions of uricosuric drugs. Fanelli GM, Weiner IM. J Clin Invest; 1973 Aug; 52(8):1946-57. PubMed ID: 4719671 [Abstract] [Full Text] [Related]
5. The effect of organic acids on renal clearance of methotrexate in man. Liegler DG, Henderson ES, Hahn MA, Oliverio VT. Clin Pharmacol Ther; 1969 Aug; 10(6):849-57. PubMed ID: 5349626 [No Abstract] [Full Text] [Related]
6. [Tubular transport of p-aminohippuric acid (PAH) in children with kidney diseases]. Devaux S, Grossmann P, Zoellner K. Acta Biol Med Ger; 1974 Aug; 32(1):121-3. PubMed ID: 4411381 [No Abstract] [Full Text] [Related]
7. Influence of hemodynamic factors on sodium reabsorption. Earley LE. Ann N Y Acad Sci; 1966 Nov 22; 139(2):312-27. PubMed ID: 5230276 [No Abstract] [Full Text] [Related]
8. [Renal excretion of gentamicin in man]. Nedden R, Fuchs T, Schröder K, Wundt W. Dtsch Med Wochenschr; 1972 Oct 06; 97(40):1496-8 passim. PubMed ID: 5071764 [No Abstract] [Full Text] [Related]
9. Studies of interactions among drugs in man at the renal level: probenecid and sulfinpyrazone. Perel JM, Dayton PG, Snell MM, Yü TF, Gutman AB. Clin Pharmacol Ther; 1969 Oct 06; 10(6):834-40. PubMed ID: 5349624 [No Abstract] [Full Text] [Related]
10. Evaluation of clearance studies in chronic kidney disease. Rosenbaum JL. J Chronic Dis; 1970 Feb 06; 22(8):507-14. PubMed ID: 5432226 [No Abstract] [Full Text] [Related]
11. [Para-aminohippuric acid clearance test: (with special reference to RPF and FF)]. Yokomatsu M, Ohno J. Rinsho Byori; 1982 Mar 06; Suppl 49():52-6. PubMed ID: 7109249 [No Abstract] [Full Text] [Related]
12. [Transport of magnesium in the renal tubules]. Wiktor Z, Kurbiel A, Jacyszyn K, Dec L. Acta Physiol Pol; 1965 Mar 06; 16(6):873-8. PubMed ID: 5868229 [No Abstract] [Full Text] [Related]
13. [Proceedings: Glomerular and tubular clearance during extra-corporeal circulation]. Larcan A, Boulange M, Laprevote-Heully MC, Fontenaille C, Pabst JC. J Urol Nephrol (Paris); 1974 Mar 06; 80(4-5):418-24. PubMed ID: 4418293 [No Abstract] [Full Text] [Related]
14. [The significance of the anion for the renal tubular transport of Na+ and for glucose and PAH transport]. Vogel G, Stoeckert I. Pflugers Arch Gesamte Physiol Menschen Tiere; 1966 Mar 06; 292(4):309-15. PubMed ID: 5234159 [No Abstract] [Full Text] [Related]
15. [Significance of isotope nephrography as compared to classical clearance tests]. Hackel F, Löbe J, Gursky S. Z Gesamte Inn Med; 1965 Sep 15; 20(18):Suppl:138-40. PubMed ID: 5879877 [No Abstract] [Full Text] [Related]
16. [Determination of the tubular transport maximum for paraaminohippuric acid (TmPAH) during fat infusions]. Dittrich P. Wien Z Inn Med; 1968 Sep 15; 49(5):192-4. PubMed ID: 5737576 [No Abstract] [Full Text] [Related]